With a wave of FDA approvals and promising clinical trials, treatment options for metastatic breast cancer are expanding fast. Amy Tiersten, MD, highlights the power of immunotherapies—especially checkpoint…
In this video, Sarah DiGeronimo, NP, and Sydney Smith, PharmD, both from Dana-Farber Cancer Institute, Boston, Massachusetts, discuss tips for the management of common side effects resulting from…
Mepolizumab, an IL-5 inhibitor, failed to alleviate moderate persistent asthma symptoms in a phase II trial of patients resistant to corticosteroids. References and Resources Flood-Page P, Swenson C,…
This study shows that compared with activation in the MTL, deactivation in the PMCs could be a more sensitive marker of early AD at functional MR imaging. References…
Douglas P. Slakey, MD, MPH, Regents Professor and Chair, Department of Surgery, Tulane University School of Medicine, discusses optimizing transplant patient outcomes. References and Resources American Liver Foundation…
